See more : Kreate Group Oyj (KREATE.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Kolmar Korea Co., Ltd. (161890.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kolmar Korea Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Genting Hong Kong Limited (GTHKF) Income Statement Analysis – Financial Results
- Excelsior Capital Limited (ECL.AX) Income Statement Analysis – Financial Results
- TOYO Co., Ltd. (TOYO) Income Statement Analysis – Financial Results
- Qualigen Therapeutics, Inc. (QLGN) Income Statement Analysis – Financial Results
- India Glycols Limited (INDIAGLYCO.NS) Income Statement Analysis – Financial Results
Kolmar Korea Co., Ltd. (161890.KS)
About Kolmar Korea Co., Ltd.
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers various cosmetic products, including skin care, makeup, baby, hair care, and body care products, as well as perfume, functional cosmetics, and qusi drugs. The company also provides prescription, over-the-counter, and bioequivalent drugs; drugs for dermatology and circulatory system; ointment and external, and oral solutions; and oral solids. In addition, it offers health functional food comprising health supplements; ingredients; special purpose food; and individually recognized health supplements. The company was founded in 2012 and is headquartered in Sejong, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,155.68B | 1,865.73B | 1,586.33B | 1,322.08B | 1,540.72B | 1,357.87B | 821.62B | 667.47B | 535.85B | 461.25B | 282.23B |
| Cost of Revenue | 1,577.55B | 1,396.90B | 1,158.20B | 895.78B | 1,108.46B | 1,000.87B | 643.81B | 513.95B | 409.57B | 360.47B | 225.56B |
| Gross Profit | 578.13B | 468.84B | 428.13B | 426.30B | 432.26B | 356.99B | 177.81B | 153.52B | 126.28B | 100.78B | 56.66B |
| Gross Profit Ratio | 26.82% | 25.13% | 26.99% | 32.24% | 28.06% | 26.29% | 21.64% | 23.00% | 23.57% | 21.85% | 20.08% |
| Research & Development | 28.06B | 24.67B | 19.93B | 18.93B | 20.84B | 15.07B | 3.43B | 3.24B | 1.95B | 722.75M | 449.75M |
| General & Administrative | 25.23B | 22.29B | 18.49B | 16.37B | 19.00B | 14.65B | 6.03B | 3.73B | 2.28B | 2.64B | 1.71B |
| Selling & Marketing | 161.71B | 156.16B | 137.04B | 116.04B | 116.53B | 112.42B | 59.65B | 50.51B | 45.61B | 40.50B | 28.11B |
| SG&A | 186.94B | 178.45B | 155.53B | 132.42B | 135.53B | 127.07B | 65.68B | 54.25B | 47.89B | 43.15B | 29.82B |
| Other Expenses | 226.98B | 192.28B | 168.41B | 153.28B | 158.08B | 124.89B | -1.32B | 467.63M | -236.59M | -2.81B | -1.27B |
| Operating Expenses | 441.98B | 395.41B | 343.87B | 304.62B | 314.45B | 267.03B | 110.83B | 80.09B | 65.56B | 53.94B | 36.99B |
| Cost & Expenses | 2,019.53B | 1,792.30B | 1,502.07B | 1,200.40B | 1,422.91B | 1,267.90B | 754.64B | 594.04B | 475.13B | 414.41B | 262.55B |
| Interest Income | 8.38B | 7.18B | 3.32B | 1.42B | 2.65B | 2.21B | 1.27B | 377.58M | 983.53M | 1.98B | 1.11B |
| Interest Expense | 45.06B | 32.69B | 30.61B | 37.28B | 53.41B | 33.41B | 3.97B | 1.00B | 2.00B | 4.25B | 3.11B |
| Depreciation & Amortization | 93.73B | 75.42B | 58.37B | 61.74B | 60.59B | 42.02B | 19.19B | 11.84B | 9.64B | 7.00B | 4.53B |
| EBITDA | 169.81B | 126.27B | 156.40B | 320.65B | 159.24B | 130.82B | 85.17B | 84.12B | 70.43B | 54.22B | 24.10B |
| EBITDA Ratio | 7.88% | 8.39% | 10.06% | 25.97% | 12.02% | 9.83% | 10.37% | 12.61% | 13.11% | 11.64% | 8.49% |
| Operating Income | 136.14B | 73.28B | 84.27B | 281.58B | 117.81B | 89.97B | 66.98B | 73.43B | 60.72B | 46.84B | 19.68B |
| Operating Income Ratio | 6.32% | 3.93% | 5.31% | 21.30% | 7.65% | 6.63% | 8.15% | 11.00% | 11.33% | 10.16% | 6.97% |
| Total Other Income/Expenses | -101.81B | -56.31B | -17.72B | -59.94B | -72.57B | -34.58B | -4.97B | -2.15B | -1.94B | -3.88B | -3.22B |
| Income Before Tax | 34.34B | 16.97B | 66.54B | 221.64B | 63.41B | 55.39B | 62.01B | 71.28B | 58.78B | 42.97B | 16.46B |
| Income Before Tax Ratio | 1.59% | 0.91% | 4.19% | 16.76% | 4.12% | 4.08% | 7.55% | 10.68% | 10.97% | 9.32% | 5.83% |
| Income Tax Expense | 9.20B | 21.07B | 23.01B | 76.95B | 29.77B | 18.58B | 13.41B | 18.10B | 13.30B | 10.16B | 2.40B |
| Net Income | 5.19B | -4.10B | 35.81B | 160.27B | 29.06B | 42.31B | 47.26B | 53.08B | 45.48B | 32.81B | 14.06B |
| Net Income Ratio | 0.24% | -0.22% | 2.26% | 12.12% | 1.89% | 3.12% | 5.75% | 7.95% | 8.49% | 7.11% | 4.98% |
| EPS | 226.90 | -179.23 | 1.57K | 7.00K | 1.28K | 1.95K | 2.24K | 2.52K | 2.16K | 1.64K | 722.00 |
| EPS Diluted | 226.90 | -179.23 | 1.57K | 7.00K | 1.28K | 1.92K | 2.20K | 2.47K | 2.12K | 1.60K | 717.00 |
| Weighted Avg Shares Out | 22.88M | 22.88M | 22.88M | 22.88M | 22.62M | 21.65M | 21.10M | 21.10M | 21.10M | 19.99M | 19.47M |
| Weighted Avg Shares Out (Dil) | 22.88M | 22.88M | 22.88M | 22.88M | 22.78M | 22.02M | 21.47M | 21.50M | 21.49M | 20.49M | 19.61M |
Source: https://incomestatements.info
Category: Stock Reports